100 related articles for article (PubMed ID: 29652183)
1. Effects of sunitinib on immunoreactivity of vimentin, E-cadherin and S100 in kidneys of streptozotocin induced diabetic mice.
Akarca-Dizakar SO; Aktuğ H; Oltulu F; Öktem G; Yavaşoğlu A; Açikgöz E; Yiğittürk G; Demir K; Uysal A
Biotech Histochem; 2018; 93(5):328-335. PubMed ID: 29652183
[TBL] [Abstract][Full Text] [Related]
2. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.
Xu ZG; Ryu DR; Yoo TH; Jung DS; Kim JJ; Kim HJ; Choi HY; Kim JS; Adler SG; Natarajan R; Han DS; Kang SW
Nephrol Dial Transplant; 2005 Mar; 20(3):524-31. PubMed ID: 15647309
[TBL] [Abstract][Full Text] [Related]
3. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
[TBL] [Abstract][Full Text] [Related]
4. The expression of intermediate filament protein nestin and its association with cyclin-dependent kinase 5 in the glomeruli of rats with diabetic nephropathy.
Liu W; Zhang Y; Liu S; Liu Q; Hao J; Shi Y; Zhao S; Duan H
Am J Med Sci; 2013 Jun; 345(6):470-7. PubMed ID: 23000950
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy.
Sanai T; Sobka T; Johnson T; el-Essawy M; Muchaneta-Kubara EC; Ben Gharbia O; el Oldroyd S; Nahas AM
Diabetologia; 2000 Jan; 43(1):91-100. PubMed ID: 10663221
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
Tunçdemir M; Öztürk M
Metabolism; 2016 Oct; 65(10):1466-77. PubMed ID: 27621182
[TBL] [Abstract][Full Text] [Related]
7. Hordenine protects against hyperglycemia-associated renal complications in streptozotocin-induced diabetic mice.
Su S; Cao M; Wu G; Long Z; Cheng X; Fan J; Xu Z; Su H; Hao Y; Li G; Peng J; Li S; Wang X
Biomed Pharmacother; 2018 Aug; 104():315-324. PubMed ID: 29775900
[TBL] [Abstract][Full Text] [Related]
8. Renal distribution of ganglioside GM3 in rat models of types 1 and 2 diabetes.
Novak A; Režić Mužinić N; Cikeš Čulić V; Božić J; Tičinović Kurir T; Ferhatović L; Puljak L; Markotić A
J Physiol Biochem; 2013 Dec; 69(4):727-35. PubMed ID: 23564406
[TBL] [Abstract][Full Text] [Related]
9. Repression of the Notch pathway prevents liver damage in streptozotocin-induced diabetic mice.
Acikgoz E; Aktug H; Yigitturk G; Demir K; Guven U; Duzagac F; Oltulu F; Yavasoglu A; Oktem G
Folia Histochem Cytobiol; 2017; 55(3):140-148. PubMed ID: 28994095
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
11. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
[TBL] [Abstract][Full Text] [Related]
13. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation attenuates metallothionein and oxidative stress changes in kidney of streptozotocin-induced diabetic rats.
Özcelik D; Nazıroglu M; Tunçdemir M; Çelik Ö; Öztürk M; Flores-Arce MF
Biol Trace Elem Res; 2012 Dec; 150(1-3):342-9. PubMed ID: 23054862
[TBL] [Abstract][Full Text] [Related]
15. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.
Guo QY; Miao LN; Li B; Ma FZ; Liu N; Cai L; Xu ZG
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E708-16. PubMed ID: 21285403
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes.
Irsik DL; Romero-Aleshire MJ; Chavez EM; Fallet RW; Brooks HL; Carmines PK; Lane PH
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F512-F520. PubMed ID: 29667912
[TBL] [Abstract][Full Text] [Related]
17. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.
Wada J; Zhang H; Tsuchiyama Y; Hiragushi K; Hida K; Shikata K; Kanwar YS; Makino H
Kidney Int; 2001 Apr; 59(4):1363-73. PubMed ID: 11260397
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes.
Komers R; Mar D; Denisenko O; Xu B; Oyama TT; Bomsztyk K
Lab Invest; 2013 May; 93(5):543-52. PubMed ID: 23508046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
